MRC — Mercator Medical SA Income Statement
0.000.00%
- PLN424.04m
- PLN256.55m
- PLN469.06m
- 87
- 61
- 28
- 63
Annual income statement for Mercator Medical SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 540 | 1,834 | 1,727 | 543 | 469 |
Cost of Revenue | |||||
Gross Profit | 80 | 1,151 | 622 | 26.4 | 11.3 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 533 | 787 | 1,264 | 724 | 556 |
Operating Profit | 7.19 | 1,048 | 463 | -181 | -87.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.07 | 1,041 | 477 | -186 | -3.79 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.03 | 936 | 445 | -191 | -22.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -2.33 | 930 | 447 | -190 | -19.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -2.33 | 930 | 447 | -190 | -19.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.244 | 88.4 | 45.5 | -20 | -4.03 |
Dividends per Share |